Drawing for Serial No. 88343475

USPTO serial 88343475

Serial No. 88343475

Reviewed by CopyMark Law Group

Reg. 6040112Status 702Registered
Filing date
Status date
Registration date
Apr 28, 2020
Examiner
SIMCOX, KYLE DUNCAN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with Serial No. 88343475?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phillip Barengolts

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geralds125 S. Wacker DriveSuite 2050Chicago, IL 60606-4450

Goods and services

ClassDescriptionStatusFirst use
042Medical laboratory services; scientific laboratory services; conducting scientific laboratory experiments remotely  in the fields of pharmaceutical, biotechnology, and materials science research; software as a service featuring software for designing laboratory experiments, for running laboratory experiments, for analyzing laboratory experiment controls, equipment, and environment data, and for analyzing laboratory experiment results; remote scientific testing services of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research design and scientific testing services; product safety and quality assurance testing services for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; toxicological safety and quality assurance testing services for pharmaceuticals, chemicals, and consumer products; software as a service featuring software for developing, executing, monitoring, and managing enterprise resource planning, experimental logistics, manufacturing execution systems, and connected factories; software as a service featuring software for running computer simulations of laboratory experiments, for running computer simulations of biological and chemical phenomena and systems, for optimizing laboratory experiment parameters with computational methods, and for comparison of computer simulations against empirically observed laboratory experiment results; software as a service featuring software for providing regulatory compliance documentation following experiments, for performing regulatory agencies audits following experiments, and for performing internal audits following experiments; software as a service featuring software for processing of un-structured, semi-structured, and structured information relating to laboratory experiments and computer simulations of laboratory experiments and biological and chemical phenomena and systemsACTIVEJul 19, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 21, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 21, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 15, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Apr 28, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 7, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 7, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 7, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 7, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 28, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 28, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 28, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 28, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 5, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 5, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2019DOCKASSIGNED TO EXAMINER—
Apr 5, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance